Smartleaf Asset Management’s Vanguard Short-Term Inflation-Protected Securities Index Fund VTIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.71M Hold
34,006
0.06% 299
2026
Q1
$1.7M Buy
34,006
+1,688
+5% +$83.9K 0.06% 280
2025
Q4
$1.6M Buy
32,318
+30,644
+1,831% +$1.53M 0.06% 274
2025
Q3
$84.7K Buy
1,674
+36
+2% +$1.81K 0.01% 1158
2025
Q2
$82.3K Sell
1,638
-4
-0.2% -$200 0.01% 940
2025
Q1
$81.9K Buy
1,642
+117
+8% +$5.74K 0.01% 923
2024
Q4
$73.8K Buy
1,525
+235
+18% +$11.5K 0.01% 987
2024
Q3
$63.7K Sell
1,290
-552
-30% -$26.9K 0.01% 837
2024
Q2
$89.4K Sell
1,842
-36
-2% -$1.73K 0.01% 608
2024
Q1
$90K Buy
1,878
+1,871
+26,729% +$89.1K 0.02% 546
2023
Q4
$332 Buy
+7
New +$332 ﹤0.01% 1087

Other funds holding VTIP

Smartleaf Asset Management's VTIP Position: Q2 2026 in Review

Smartleaf Asset Management held its Vanguard Short-Term Inflation-Protected Securities Index Fund (VTIP) position steady in Q2 2026 at 34,006 shares worth $1.71M. The position accounts for 0.06% of the portfolio, ranked #299.

Smartleaf Asset Management first reported a position in VTIP in Q4 2023 and has held it in 11 quarters since. 954 funds tracked by Wall St. Rank hold VTIP as of Q2 2026.

  • Smartleaf Asset Management held 34,006 shares of Vanguard Short-Term Inflation-Protected Securities Index Fund worth $1.71M as of Q2 2026.
  • Smartleaf Asset Management left its Vanguard Short-Term Inflation-Protected Securities Index Fund share count unchanged in Q2 2026.
  • Vanguard Short-Term Inflation-Protected Securities Index Fund made up 0.06% of Smartleaf Asset Management's portfolio in Q2 2026, its #299 holding.
  • Smartleaf Asset Management first reported a position in Vanguard Short-Term Inflation-Protected Securities Index Fund in Q4 2023 and has held it in 11 quarters since.
  • 954 funds tracked by Wall St. Rank held Vanguard Short-Term Inflation-Protected Securities Index Fund as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.